← Back to All Filings

SI-BONE Director Sells Shares for Tax Withholding

Low SignificanceNovember 4, 2025 at 7:01:54 PM EST

SI-BONE, Inc.

$SIBN4CIK: 0001459839

Subscribe to track SIBN

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

SI-BONE Director Sells Shares for Tax Withholding

Company: SI-BONE, Inc. (SIBN) Form: 4 | Filed: 2025-11-04 Significance: Low

Insider: DUNN JEFFREY W Title: null | Relationship: Director

Transaction: • Type: Sell (Tax Withholding) • Shares: 293 • Price: $14.80 • Value: $4,338 • Owned After (Direct): 10,831

Key Insight: This is a non-discretionary "sell to cover" transaction to satisfy tax obligations from vested restricted stock units. It does not represent a change in the insider's investment outlook.

Market Context: The transaction value is negligible compared to SI-BONE's $0.64 billion market cap, representing less than 0.001% of the company's value.

Comprehensive Analysis

SEC Filing Analysis: SI-BONE, Inc. (SIBN)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director executed a minor, non-discretionary sale of common stock to cover tax liabilities associated with vested restricted stock units (RSUs).
  • Market Impact: Neutral. The transaction is immaterial and automated, signaling no change in insider sentiment.

Company Information

FieldValue
CompanySI-BONE, Inc.
Ticker SymbolSIBN
CIK0001459839
IndustrySurgical & Medical Instruments & Apparatus

Insider Information

FieldValue
NameDUNN JEFFREY W
CIK0001035986
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-03
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved293
Price Per Share$14.8038
Total Value$4,337.51
Shares Owned After (Direct)10,831
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$4,337.51
% of Market Cap<0.001%
Shares Transacted293
% of Shares Outstanding<0.001%
Post-Transaction Ownership (Total)129,181 shares (0.299% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction value of approximately $4,338 is negligible against the company's market capitalization of $640 million.
  • Ownership Concentration: The sale has a minimal impact on the director's total holdings. Post-transaction, the insider continues to hold 129,181 shares (10,831 direct and 118,350 indirect via a trust), representing approximately 0.3% of total shares outstanding.
  • Transaction Significance: The sale is classified as low significance. It represents less than 0.001% of both the market cap and shares outstanding. The nature of the sale, as a "sell to cover" for tax purposes, further diminishes its importance as a market signal.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a routine, non-discretionary sale to cover tax obligations, as stated in the filing's footnotes. Such sales are common and do not reflect an insider's discretionary trading decision or sentiment towards the company's future prospects.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The number of shares sold is too small to affect trading volume.
  • Sentiment Indicator: Neutral. This type of transaction is not considered bullish or bearish by the market.

Additional Context

Transaction Notes

  • Special Circumstances: Footnote F1 explicitly states, "The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units... and does not represent a discretionary trade by the Reporting Person."
Topics:#SECFiling#InsiderTrading#SIBN#SIBONE#Form4#InsiderSell#StockMarket#Investing#Healthcare

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.